ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Kumar Discusses Genetic Abnormalities in Myeloma

Shaji K. Kumar, MD
Published: Tuesday, Nov 21, 2017



Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses genetic abnormalities in multiple myeloma.

There has been significant progress toward understanding genetic variations in patients with multiple myeloma.

Through the use of FISH testing, abnormalities such as 17p deletion are discovered. Though there are abnormalities such as translocation present at diagnosis, these may change throughout a patient’s treatment course or when they relapse, says Kumar.


Shaji K. Kumar, MD, professor of medicine, Mayo Clinic, discusses genetic abnormalities in multiple myeloma.

There has been significant progress toward understanding genetic variations in patients with multiple myeloma.

Through the use of FISH testing, abnormalities such as 17p deletion are discovered. Though there are abnormalities such as translocation present at diagnosis, these may change throughout a patient’s treatment course or when they relapse, says Kumar.



View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 18th Annual International Lung Cancer Congress®Oct 31, 20181.5
Provider and Caregiver Connection™: Addressing Patient Concerns While Managing Chemotherapy Induced Nausea and VomitingOct 31, 20182.0
Publication Bottom Border
Border Publication
x